CorneaGen
  • SURGEON PORTAL
  • Contact Us
  • CORNEAL TISSUE
    • Tissue Overview
    • Tissue Services
      • DSAEK
      • DMEK
      • Geuder Pre-Loaded Glass Cannula
      • Ampho B
      • PKP
      • ALK
      • BrightMEM
      • FLAK
      • Non-Sterile Sclera
    • Tissue Reimbursement
    • Adverse Reaction Reporting
    • Regulatory Information
    • Request Tissue
  • Sterile Tissue
    • CTAK
    • VisionGraft
      • Glaucoma
      • Cornea
    • Sclera
    • Reimbursement
      • CTAK Reimbursement
      • VisionGraft Reimbursement
    • Adverse Reaction Reporting
    • Regulatory Information
  • CTAK
  • Products
    • Products Overview
    • EndoSerter-PL
    • EndoSerter
    • Cannula
    • Geuder Pre-Loaded Glass Cannula
    • DescePro System
    • Donor Punch
    • Recipient Trephine
    • Intacs
  • Education
    • Educational Videos
    • Wet Labs
    • Fellows Program
  • About Us
    • Our People
    • Our Partners
    • Our Locations
    • Reimbursement
    • Gift of Sight
    • News & Events
    • Core Commitments
    • Innovation
    • Careers
Request Tissue Contact Us
CorneaGen Expands Eye Recovery Services to California

CorneaGen Expands Eye Recovery Services to California

January 10, 2024

CorneaGen to assume eye recovery services for multiple hospitals in northern and southern California.

Seattle, WA – Jan 10, 2024 – Seattle-based CorneaGen is excited to announce an expansion of their eye recovery services throughout northern and southern California.

Through this expansion of service, CorneaGen will now provide both eye recovery and processing services of donor tissue for facilities throughout the state, resulting in an even better experience for the patients, families, and staff of their California partner facilities.

“It’s a great honor to broaden CorneaGen’s recovery responsibilities to California, augmenting our vast processing activities in the state” said Bernie Iliakis, President and CEO of CorneaGen. “Our leadership and staff have deep eye recovery experience, having provided this offering on a very large scale to multiple regions. In fact, we launched eye recovery services to this hospital group in 2009, so it comes full circle.”

With a mission to provide the highest quality donor tissue and products that transform how ophthalmologists treat and care for every person impacted by corneal disease, CorneaGen accomplishes this work through its donation and ophthalmic industry partnerships.  This expansion will increase collaboration with the esteemed California-based organ procurement organizations of Donor Network West, One Legacy, and Sierra Donor Services as well as eye bank partner Lions World Vision Institute.

“Eye recovery services had been provided by SightLife in this region for many years, but after Lions World Vision Institute acquired SightLife in 2022, we determined that this region could be better supported by CorneaGen allowing us to focus our resources in other regions around the country. We are pleased to collaborate with CorneaGen to transition this region to them” said Jason Woody, President and CEO of Lions World Vision Institute.

The world’s leading provider of ocular tissue, CorneaGen’s multiple locations and local relationships are key to helping patients throughout the U.S. and the world. The expansion of recovery services to California continues the company’s commitment to donors and their families, while driving innovation and strengthening their position as market leader.

About CorneaGen
CorneaGen’s mission is to provide the highest quality donor tissue, unparalleled customer service and superior products that transform how ophthalmologists treat and care for every person impacted by corneal disease. Through continuous innovations in tissue processing technology and surgical devices, advocacy for patient access and simplified payor reimbursement policies, CorneaGen is advancing the next generation of cornea care.  As the world’s leading provider of ocular tissue, CorneaGen has multiple locations and local partnerships throughout the U.S. to deliver the life-changing gift of sight to tens of thousands of people each year. Read more at https://corneagen.com/

Media contacts
Jared Young, CorneaGen VP Marketing and Communications
jared.young@corneagen.com
619-518-0734

Julie Fogerson, Fearey Group
jfogerson@feareygroup.com
425-503-3154

Recent Articles

  • Bernie’s Quarterly Update – November 2024

    Bernie’s Quarterly Update – November 2024

    A message from Bernie Iliakis, President & CEO of CorneaGen...

    READ MORE
  • Bernie’s Quarterly Update – July 2024

    Bernie’s Quarterly Update – July 2024

    A message from Bernie Iliakis, President & CEO of CorneaGen...

    READ MORE
  • CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes

    CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes

    CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes Advanced...

    READ MORE
  • CTAK Update from ASCRS 2024

    CTAK Update from ASCRS 2024

    Hear from Dr. Steven Greenstein and Dr. Peter Hersh from...

    READ MORE
Navigation
  • Corneal Tissue
  • Products
  • Innovation
  • Education
  • About Us
  • Request Tissue
Helpful Information
  • Reimbursement assistance
  • Adverse reaction reporting
  • KAMRA Support
  • Careers
Legal
  • Privacy Policy
  • Terms and conditions
  • Regulatory Information
Connect
  • Contact Us
CorneaGen

©2025 CorneaGen

CorneaGen